Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Usana Health Sciences (USNA) Interest Expenses (2016 - 2026)

Usana Health Sciences (USNA) has disclosed Interest Expenses for 14 consecutive years, with $49000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Interest Expenses changed 0.0% to $49000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $848000.0, a 185.52% increase, with the full-year FY2024 number at $281000.0, up 7.25% from a year prior.
  • Interest Expenses was $49000.0 for Q3 2025 at Usana Health Sciences, down from $259000.0 in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $411000.0 in Q1 2025 to a low of -$1.6 million in Q1 2022.
  • A 5-year average of -$3421.1 and a median of $43000.0 in 2023 define the central range for Interest Expenses.
  • Peak YoY movement for Interest Expenses: tumbled 98.69% in 2021, then skyrocketed 690.38% in 2025.
  • Usana Health Sciences' Interest Expenses stood at $18000.0 in 2021, then skyrocketed by 77.78% to $32000.0 in 2022, then surged by 353.12% to $145000.0 in 2023, then dropped by 11.03% to $129000.0 in 2024, then tumbled by 62.02% to $49000.0 in 2025.
  • Per Business Quant, the three most recent readings for USNA's Interest Expenses are $49000.0 (Q3 2025), $259000.0 (Q2 2025), and $411000.0 (Q1 2025).